<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical relapse of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> is characterised by increased neutrophil migration into the intestine </plain></SENT>
<SENT sid="1" pm="."><plain>The site of the neutrophil chemoattractant(s), whether <z:chebi fb="2" ids="8069">luminal</z:chebi> or mucosal, may be important since, on contact with a chemoattractant, neutrophils cause indiscriminate damage to their immediate surroundings by generating reactive oxygen species and by lysosomal enzyme release </plain></SENT>
<SENT sid="2" pm="."><plain>If this happens within the mucosa, <z:mp ids='MP_0001845'>inflammation</z:mp> should correlate significantly with tissue damage as assessed by <z:mp ids='MP_0001914'>bleeding</z:mp>, but if it occurs within the intestinal lumen, the <z:mp ids='MP_0001845'>inflammation</z:mp> would be disproportionately greater than the <z:mp ids='MP_0001914'>bleeding</z:mp> such as is seen in classical exudation </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0001858'>Intestinal inflammation</z:mp> and <z:mp ids='MP_0001914'>bleeding</z:mp> were quantitated with the simultaneous use of <z:chebi fb="1" ids="30430">indium</z:chebi>-111 labelled neutrophils (four day faecal excretion of <z:chebi fb="1" ids="30430">indium</z:chebi>-111) and <z:chebi fb="0" ids="50076">chromium-51</z:chebi> labelled red cells in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (n = 12), <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (n = 15), and <z:chebi fb="1" ids="35475">NSAID</z:chebi> induced <z:hpo ids='HP_0002242'>enteropathy</z:hpo> (n = 34) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001858'>Intestinal inflammation</z:mp> and blood loss correlated significantly (Spearman) in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (20.3% v 6.5 ml/d (median) r: 0.85, p &lt; 0.001) and NSAiD <z:hpo ids='HP_0002242'>enteropathy</z:hpo> (1.6% v 1.9 ml/d, r: 0.60, p &lt; 0.01) but not in <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (17.0% v 2.1 ml/d, r: 0.38, p &gt; 0.1) </plain></SENT>
<SENT sid="5" pm="."><plain>For a given <z:chebi fb="1" ids="30430">indium</z:chebi>-111 excretion, patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> had significantly greater (p &lt; 0.01) blood loss than patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that the predominant site of neutrophil chemoattractants may be within the mucosa in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:chebi fb="1" ids="35475">NSAID</z:chebi> <z:hpo ids='HP_0002242'>enteropathy</z:hpo> and within the lumen in <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> </plain></SENT>
</text></document>